LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 72.52 | 84.90 | 965 | 9214 | 0.1047 | 0.4326 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 72.52 | 84.90 | 108 | 9214 | 0.0117 | 0.0362 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 72.52 | 84.90 | 1343 | 9214 | 0.1458 | 0.5043 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 74.22 | 84.90 | 913 | 9343 | 0.0977 | 0.4194 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 74.22 | 84.90 | 960 | 9343 | 0.1028 | 0.4299 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 74.22 | 84.90 | 112 | 9343 | 0.0120 | 0.0417 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 74.22 | 84.90 | 1353 | 9343 | 0.1448 | 0.5042 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 75.93 | 84.90 | 957 | 8970 | 0.1067 | 0.4338 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 75.93 | 84.90 | 1046 | 8970 | 0.1166 | 0.4528 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 75.93 | 84.90 | 129 | 8970 | 0.0144 | 0.0642 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 75.93 | 84.90 | 1394 | 8970 | 0.1554 | 0.5162 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 77.64 | 84.90 | 847 | 9245 | 0.0916 | 0.4049 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 77.64 | 84.90 | 917 | 9245 | 0.0992 | 0.4214 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 77.64 | 84.90 | 140 | 9245 | 0.0151 | 0.0767 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 77.64 | 84.90 | 1371 | 9245 | 0.1483 | 0.5085 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 79.34 | 84.90 | 906 | 9051 | 0.1001 | 0.4212 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 79.34 | 84.90 | 1026 | 9051 | 0.1134 | 0.4476 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 79.34 | 84.90 | 152 | 9051 | 0.0168 | 0.0903 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 79.34 | 84.90 | 1445 | 9051 | 0.1596 | 0.5231 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 81.05 | 84.90 | 848 | 8863 | 0.0957 | 0.4094 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 81.05 | 84.90 | 1006 | 8863 | 0.1135 | 0.4458 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 81.05 | 84.90 | 158 | 8863 | 0.0178 | 0.0971 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 81.05 | 84.90 | 1507 | 8863 | 0.1700 | 0.5356 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 82.75 | 84.90 | 902 | 8621 | 0.1046 | 0.4255 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 82.75 | 84.90 | 1092 | 8621 | 0.1267 | 0.4670 | MN20160318_Q02 | E08 |